Clonazepam for probable REM sleep behavior disorder in Parkinson’s disease: A randomized placebo-controlled trial.

Clonazepam for probable REM sleep behavior disorder in Parkinson’s disease: A randomized placebo-controlled trial.
Related ArticlesClonazepam for probable REM sleep behavior disorder in Parkinson's disease: A randomized placebo-controlled trial. J Neurol Sci. 2019 Apr 23;401:81-86 Authors: Shin C, Park H, Lee WW, Kim HJ, Kim HJ, Jeon B Abstract BACKGROUND: Clonazepam is considered to be a first-line treatment for rapid eye movement sleep-related behavior disorder (RBD) in Parkinson's disease (PD). The purpose of this ... read more
Source: PubMedPublished on 2019-04-30